Inventor · disambiguated record
Samuel Bartlett
Also filed as: BARTLETT SAMUEL
14 granted patents·8 pending applications·48 citations·filing 2019–2025
88Inventor score
Files withENANTA PHARM INC22
Top patents by PatentIndex Score
22 records- 0197US11858945B2Alkyne-containing antiviral agentsENANTA PHARM INC·Filed 2022·Granted Jan 2, 2024·7 cites·16 claims
- 0295US11358953B2Functionalized peptides as antiviral agentsENANTA PHARM INC·Filed 2021·Granted Jun 14, 2022·15 cites·10 claims
- 0394US10865211B2Functionalized heterocycles as antiviral agentsENANTA PHARM INC·Filed 2019·Granted Dec 15, 2020·11 cites·17 claims
- 0493US11891393B2Functionalized heterocycles as antiviral agentsENANTA PHARM INC·Filed 2021·Granted Feb 6, 2024·2 cites·20 claims
- 0593US11198693B2Functionalized heterocycles as antiviral agentsENANTA PHARM INC·Filed 2019·Granted Dec 14, 2021·6 cites·20 claims
- 0692US11058678B2Substituted heterocycles as antiviral agentsENANTA PHARM INC·Filed 2019·Granted Jul 13, 2021·7 cites·21 claims
- 0783US12264159B2Functionalized heterocycles as antiviral agentsENANTA PHARM INC·Filed 2023·Granted Apr 1, 2025·0 cites·19 claims
- 0868US2022041652A1Functionalized peptides as antiviral agentsENANTA PHARM INC·Filed 2021·Application pending·0 cites
- 0967US2022033383A1Functionalized peptides as antiviral agentsENANTA PHARM INC·Filed 2021·Application pending·0 cites
- 1063US11993600B2Saturated spirocyclics as antiviral agentsENANTA PHARM INC·Filed 2022·Granted May 28, 2024·0 cites·16 claims
- 1162US11377450B2Functionalized heterocycles as antiviral agentsENANTA PHARM INC·Filed 2020·Granted Jul 5, 2022·0 cites·21 claims
- 1261US2024325409A1Fused Heterotetracyclic Antiviral AgentsENANTA PHARM INC·Filed 2024·Application pending·0 cites
- 1360US2024368096A1Fused Heterobicyclic Antiviral AgentsENANTA PHARM INC·Filed 2024·Application pending·0 cites
- 1458US12479854B2Spiropyrrolidine derived antiviral agentsENANTA PHARM INC·Filed 2022·Granted Nov 25, 2025·0 cites·22 claims
- 1558US12145941B2Heterocyclic antiviral agentsENANTA PHARM INC·Filed 2022·Granted Nov 19, 2024·0 cites·14 claims
- 1658US2024140922A1Fused heterobicyclic antiviral agentsENANTA PHARM INC·Filed 2023·Application pending·0 cites
- 1754US11802125B2Functionalized heterocyclic compounds as antiviral agentsENANTA PHARM INC·Filed 2021·Granted Oct 31, 2023·0 cites·9 claims
- 1854US2022048944A1Functionalized peptides as antiviral agentsENANTA PHARM INC·Filed 2021·Application pending·0 cites
- 1953US11738019B2Substituted heterocycles as antiviral agentsENANTA PHARM INC·Filed 2020·Granted Aug 29, 2023·0 cites·15 claims
- 2052US11236108B2Functionalized heterocycles as antiviral agentsENANTA PHARM INC·Filed 2020·Granted Feb 1, 2022·0 cites·15 claims
- 2152US2025313569A1Pharmaceutical Compounds And Compositions As Modulators Of MAS-Related G-Protein Receptor X2ENANTA PHARM INC·Filed 2025·Application pending·0 cites
- 2245US2025304542A1Fused Heterobicyclic Antiviral AgentsENANTA PHARM INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Samuel Bartlett files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →